DocGo Inc. Share-based Payment Arrangement, Expense
DocGo Inc. (DCGO) reported Share-based Payment Arrangement, Expense of $2.66 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-17
- DocGo Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $2.66M, a 44.98% decline year-over-year.
- DocGo Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $3.22M, a 33.24% decline year-over-year.
- DocGo Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $3.14M, a 19.15% decline year-over-year.
- DocGo Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $4.65M, a 47.37% increase year-over-year.
- DocGo Inc. share-based payment arrangement, expense for fiscal 2025 was $17.44M, a 27.93% increase from fiscal 2024.
- DocGo Inc. share-based payment arrangement, expense for fiscal 2024 was $13.63M, a 34.98% decline from fiscal 2023.
- DocGo Inc. share-based payment arrangement, expense for fiscal 2023 was $20.97M, a 160.34% increase from fiscal 2022.
- DocGo Inc. share-based payment arrangement, expense for fiscal 2022 was $8.05M, a 485.21% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $2.66M 10-Q · filed 2026-08-17 | $5.88M 10-Q · filed 2026-08-17 | $9.02M derived: sum of 3 quarters · filed 2026-08-17 | $13.67M derived: sum of 4 quarters · filed 2026-08-17 | |
| 2026-03-31 | $3.22M 10-Q · filed 2026-05-11 | $6.36M derived: sum of 2 quarters · filed 2026-05-11 | $11.01M derived: sum of 3 quarters · filed 2026-05-11 | $15.84M derived: sum of 4 quarters · filed 2026-08-17 | |
| 2025-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.79M derived: sum of 2 quarters · filed 2026-03-16 | $12.61M derived: sum of 3 quarters · filed 2026-08-17 | $17.44M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $4.65M 10-Q · filed 2025-11-10 | $9.48M derived: sum of 2 quarters · filed 2026-08-17 | $14.31M 10-Q · filed 2025-11-10 | $18.18M derived: sum of 4 quarters · filed 2026-08-17 | |
| 2025-06-30 | $4.83M 10-Q · filed 2026-08-17 | $9.66M 10-Q · filed 2026-08-17 | $13.54M derived: sum of 3 quarters · filed 2026-08-17 | $16.69M derived: sum of 4 quarters · filed 2026-08-17 | |
| 2025-03-31 | $4.83M 10-Q · filed 2026-05-11 | $8.71M derived: sum of 2 quarters · filed 2026-05-11 | $11.86M derived: sum of 3 quarters · filed 2026-05-11 | $14.48M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $3.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $7.03M derived: sum of 2 quarters · filed 2026-03-16 | $9.65M derived: sum of 3 quarters · filed 2026-03-16 | $13.63M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $3.16M 10-Q · filed 2025-11-10 | $5.77M derived: sum of 2 quarters · filed 2025-11-10 | $9.76M 10-Q · filed 2025-11-10 | $15.56M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-06-30 | $2.61M 10-Q · filed 2025-08-07 | $6.60M 10-Q · filed 2025-08-07 | $12.41M derived: sum of 3 quarters · filed 2026-03-16 | $15.77M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-03-31 | $3.99M 10-Q · filed 2025-05-08 | $9.80M derived: sum of 2 quarters · filed 2026-03-16 | $13.16M derived: sum of 3 quarters · filed 2026-03-16 | $16.51M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2023-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $9.17M derived: sum of 2 quarters · filed 2026-03-16 | $12.52M derived: sum of 3 quarters · filed 2026-03-16 | $20.97M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $3.36M 10-Q · filed 2024-11-07 | $3.36M 10-Q · filed 2023-11-06 | $6.71M derived: sum of 2 quarters · filed 2024-11-07 | $15.16M 10-Q · filed 2024-11-07 | $18.68M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.35M 10-Q · filed 2024-08-07 | $11.80M 10-Q · filed 2024-08-07 | $15.32M derived: sum of 3 quarters · filed 2025-02-27 | $16.43M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $8.45M 10-Q · filed 2024-05-08 | $11.97M derived: sum of 2 quarters · filed 2025-02-27 | $13.08M derived: sum of 3 quarters · filed 2025-02-27 | $15.08M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.63M derived: sum of 2 quarters · filed 2025-02-27 | $6.63M derived: sum of 3 quarters · filed 2025-02-27 | $8.05M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $1.11M 10-Q · filed 2023-11-06 | $3.11M derived: sum of 2 quarters · filed 2023-11-06 | $4.53M 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | $2.00M 10-Q · filed 2023-08-08 | $3.42M 10-Q · filed 2023-08-08 | |||
| 2021-12-31 | $1.38M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |